Randell Edward W, Mathews Maria S, Zhang Hongwei, Seraj Jim S, Sun Guang
Division of Laboratory Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada A1B 3V6.
Clin Biochem. 2005 Sep;38(9):799-805. doi: 10.1016/j.clinbiochem.2005.04.008.
To identify independent predictors of serum butyrylcholinesterase (BuChE) activity and examine its relationship with the metabolic syndrome.
Serum BuChE activity was measured and metabolic syndrome risk factors were assessed in 1097 healthy subjects recruited from the Newfoundland adult population.
Serum BuChE activity was related to insulin homeostasis and correlated with fasting insulin levels (r = 0.266, P < 0.001) and insulin resistance (HOMA-R) index (r = 0.292, P < 0.001) and was higher in individuals with risk factors for the metabolic syndrome. BuChE activity was higher in males than in females and correlated most strongly with serum triglyceride levels (r = 0.363, P < 0.001) and indicators of abdominal obesity (r = 0.355, P < 0.001). Percent trunk fat (beta = 0.185, P < 0.001), triglyceride levels (beta = 0.225, P < 0.001), sex (beta = -0.202, P = 0.001), glucose (beta = 0.209, P < 0.001), insulin (beta = 0.360, P = 0.011), HOMA-R (beta = -0.319, P = 0.044), and age (beta = 0.086, P = 0.002) were independent predictors of BuChE activity.
These results suggest the involvement of BuChE in the pathophysiological process constituting the metabolic syndrome. Whether increased BuChE activity precedes or follows the development of risk factors is not known.
确定血清丁酰胆碱酯酶(BuChE)活性的独立预测因素,并研究其与代谢综合征的关系。
对从纽芬兰成年人群中招募的1097名健康受试者测量血清BuChE活性,并评估代谢综合征危险因素。
血清BuChE活性与胰岛素稳态相关,与空腹胰岛素水平(r = 0.266,P < 0.001)和胰岛素抵抗(HOMA-R)指数(r = 0.292,P < 0.001)相关,且在有代谢综合征危险因素的个体中更高。男性的BuChE活性高于女性,且与血清甘油三酯水平(r = 0.363,P < 0.001)和腹部肥胖指标(r = 0.355,P < 0.001)相关性最强。躯干脂肪百分比(β = 0.185,P < 0.001)、甘油三酯水平(β = 0.225,P < 0.001)、性别(β = -0.202,P = 0.001)、血糖(β = 0.209,P < 0.001)、胰岛素(β = 0.360,P = 0.011)、HOMA-R(β = -0.319,P = 0.044)和年龄(β = 0.086,P = 0.002)是BuChE活性的独立预测因素。
这些结果表明BuChE参与了构成代谢综合征的病理生理过程。尚不清楚BuChE活性增加是在危险因素出现之前还是之后。